Literature DB >> 3311024

Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties.

A Reboul1, M H Prandini, M G Colomb.   

Abstract

The effects of proteolysis and deglycosylation on C1 inhibitor (C1Inh) were tested with respect to both its ability to form complexes with C1s and its capacity to block C1 autoactivation. Limited proteolysis of C1Inh by Staphylococcus aureus V8 proteinase, proline-specific endopeptidase or elastase generated a major high-Mr (approximately 86,000) fragment. In contrast with the fragment produced by elastase, which was inactive, the fragments resulting from V8 proteinase and proline-specific endopeptidase treatment retained activity. Deglycosylation with N-glycanase or O-glycanase, or both, had no major effect on the functional activity of C1Inh.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311024      PMCID: PMC1147961          DOI: 10.1042/bj2440117

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

Authors:  V H DONALDSON; R R EVANS
Journal:  Am J Med       Date:  1963-07       Impact factor: 4.965

2.  A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s.

Authors:  A Reboul; G J Arlaud; R B Sim; M G Colomb
Journal:  FEBS Lett       Date:  1977-07-01       Impact factor: 4.124

3.  Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera.

Authors:  K B Reid; D M Lowe; R R Porter
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

4.  [Isolation and characterization of C1-Inactivator from human plasma].

Authors:  H Haupt; N Heimburger; T Kranz; H G Schwick
Journal:  Eur J Biochem       Date:  1970-12

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.

Authors:  C D Forbes; J Pensky; O D Ratnoff
Journal:  J Lab Clin Med       Date:  1970-11

7.  The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.

Authors:  R B Sim; R R Porter; K B Reid; I Gigli
Journal:  Biochem J       Date:  1977-05-01       Impact factor: 3.857

8.  Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.

Authors:  P C Harpel; N R Cooper
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

9.  Staphylococcal protease: a proteolytic enzyme specific for glutamoyl bonds.

Authors:  J Houmard; G R Drapeau
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

10.  Human serum inhibitor of C'1 esterase: identity with alpha-2-neuraminoglycoprotein.

Authors:  J Pensky; H G Schwick
Journal:  Science       Date:  1969-02-14       Impact factor: 47.728

View more
  7 in total

1.  N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.

Authors:  Dongxu Liu; Cort C Cramer; Jennifer Scafidi; Alvin E Davis
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site.

Authors:  R B Parad; J Kramer; R C Strunk; F S Rosen; A E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Metabolic alteration of the N-glycan structure of a protein from patients with a heterozygous protein deficiency.

Authors:  Fuming Zhang; Andrew D Bries; Sybil C Lang; Qun Wang; David W Murhammer; John M Weiler; Robert J Linhardt
Journal:  Biochim Biophys Acta       Date:  2004-12-24

4.  N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice.

Authors:  Dongxu Liu; Xiaogang Gu; Jennifer Scafidi; Alvin E Davis
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

5.  N- and O-glycosylation Analysis of Human C1-inhibitor Reveals Extensive Mucin-type O-Glycosylation.

Authors:  Kathrin Stavenhagen; H Mehmet Kayili; Stephanie Holst; Carolien A M Koeleman; Ruchira Engel; Diana Wouters; Sacha Zeerleder; Bekir Salih; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2017-12-12       Impact factor: 5.911

6.  A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.

Authors:  Michele Mutti; Katharina Ramoni; Gábor Nagy; Eszter Nagy; Valéria Szijártó
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

Review 7.  Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.

Authors:  Steven P Grover; Nigel Mackman
Journal:  Front Cardiovasc Med       Date:  2022-05-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.